Cue Biopharma And 2 Other Stocks Under $3 Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insiders at Kingstone Companies, Inc. (KINS), International Isotopes Inc. (INIS), and Cue Biopharma, Inc. (CUE) have recently purchased shares, indicating confidence in their respective companies. KINS posted a wider-than-expected quarterly loss, while INIS reported a revenue increase for the six months ended June 30, 2023, and CUE posted upbeat quarterly results.
August 30, 2023 | 11:49 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kingstone Companies' COO purchased 5,811 shares despite the company posting a wider-than-expected quarterly loss.
The insider purchase at KINS could indicate confidence in the company's future prospects despite the recent quarterly loss. However, the loss could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Cue Biopharma's President and CSO purchased 4,000 shares following the company's upbeat quarterly results.
The insider purchase at CUE, along with the positive quarterly results, could indicate a positive outlook for the company and potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
International Isotopes' President purchased 3,950 shares following the company's reported revenue increase for the six months ended June 30, 2023.
The insider purchase at INIS, coupled with the reported revenue increase, could indicate a positive outlook for the company and potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100